Effect of Plasma Exchange in Thyroid Storm With Consideration of Its Distribution Into the Extravascular Space.

Graves disease extravascular space plasma exchange thyroid storm

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Apr 2020
Historique:
received: 11 12 2019
accepted: 25 02 2020
entrez: 25 3 2020
pubmed: 25 3 2020
medline: 25 3 2020
Statut: epublish

Résumé

Plasma exchange (PE), which directly removes some plasma thyroid hormones, is a treatment option for thyroid storm. However, the effect of PE has not been accurately assessed yet. Here we assessed the effect of PE in a patient with thyroid storm while taking into consideration the distribution of thyroid hormones in the extravascular space. A 51-year-old woman with thyroid storm underwent 2 PE procedures at our hospital. By measuring changes in thyroid hormone levels in plasma, fresh frozen plasma (FFP) used, and waste fluid during each 2.5-hour PE procedure, we calculated the efficiency of thyroid hormone removal based on the hypothesis that total thyroid hormone content before and after PE is the same. During the patient's first PE procedure, the estimated thyroxine (T

Identifiants

pubmed: 32206741
doi: 10.1210/jendso/bvaa023
pii: bvaa023
pmc: PMC7080405
doi:

Types de publication

Case Reports

Langues

eng

Pagination

bvaa023

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Endocrine Society 2020.

Références

J Clin Invest. 1939 Jan;18(1):59-65
pubmed: 16694645
JAMA. 1970 Nov 16;214(7):1275-9
pubmed: 5536311
Calif Med. 1970 Aug;113(2):41-5
pubmed: 5538193
Ther Apher Dial. 2011 Dec;15(6):522-31
pubmed: 22107688
J Clin Apher. 2009;24(3):111-4
pubmed: 19484727
J Clin Invest. 1937 May;16(3):317-28
pubmed: 16694481
Clin Endocrinol (Oxf). 1982 Feb;16(2):199-206
pubmed: 7067159
J Clin Invest. 1974 Jul;54(1):156-64
pubmed: 4209664
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
Endocr J. 2016 Dec 30;63(12):1025-1064
pubmed: 27746415
Ther Apher Dial. 2004 Aug;8(4):347-9
pubmed: 15274688

Auteurs

Mai Shinohara (M)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Toyoyoshi Uchida (T)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Takashi Funayama (T)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Mika Watanabe (M)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Makio Kusaoi (M)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Ken Yamaji (K)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Naoto Tamura (N)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Hiromasa Goto (H)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Hiroaki Sato (H)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Hirotaka Watada (H)

Department of Metabolism & Endocrinology, Juntendo University Graduate School, Tokyo, Japan.

Classifications MeSH